Production (Stage)
Vigil Neuroscience, Inc.
VIGL
$7.89
$0.010.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.95% | -23.75% | 9.28% | -6.45% | 10.07% |
| Total Depreciation and Amortization | 9.73% | -0.88% | 0.88% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.76% | 0.31% | 2.57% | 13.45% | -28.26% |
| Change in Net Operating Assets | -247.46% | -85.74% | 576.70% | 171.90% | -224.53% |
| Cash from Operations | -31.71% | -521.79% | 127.74% | 29.15% | -41.08% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.36% | 147.22% | -1,680.36% | -93.63% | 54.35% |
| Cash from Investing | 196.72% | 147.22% | -1,687.93% | -93.66% | 54.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 199.08% | 8,598.04% | 466.67% | -99.83% | 9,681.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 199.08% | -77.66% | 220,577.78% | -99.83% | 9,681.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 314.41% | -177.49% | 152.49% | -6,154.98% | 95.19% |